{"text": "Potent gene regulatory and antiproliferative activities of 20-methyl analogues of 1 , 25 dihydroxyvitamin D3 .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The biological active form of vitamin D3 , 1 , 25-dihydroxyvitamin D3 ( VD ) , regulates cellular growth and differentiation .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This provides the hormone with an interesting therapeutic potential .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "However , hypercalcemia is a side effect , which is caused by VD 's classical action , the regulation of calcium homeostasis .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This made the need for VD analogues with selectively increased cell regulatory properties .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Studies with 20-epi analogues pointed out the importance of the carbon-20 position and led to the development of 20-methyl derivatives of VD .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In this report the biological properties of the compounds ZK161422 and ZK157202 , which are 20-methyl - and 20-methyl-23-eneanalogues , respectively , have been analyzed in comparison with VD .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Both compounds show about 2-fold lower affinity to the <extra_id_0> VD receptor <extra_id_2> Protein <extra_id_1> ( <extra_id_0> VDR <extra_id_2> Protein <extra_id_1> ) than VD .", "event": "<extra_id_0> <extra_id_0> Binding lower affinity <extra_id_1> <extra_id_0> Theme VDR <extra_id_1> <extra_id_1>"}
{"text": "However , compared to VD , their antiproliferative effect is up to 30-fold higher on human peripheral blood mononuclear cells and even up to 300-fold higher on human breast cancer MCF-7 cells .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Whereas the hypercalcemic effect for ZK157202 is also increased 10-fold , ZK161422 has the same calcium-mobilizing potency as VD .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Moreover , ZK161422 , but not ZK157202 , showed preference for gene activation from a promoter carrying a VD response element with a palindromic arrangement of two hexameric receptor binding sites spaced by 9 nucleotides ( IP9 ) rather than for activation from a response element formed by a direct repeat spaced by 3 nucleotides ( DR3 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This observation supports a model , in which promoter selectivity reflects the selectively increased antiproliferative effect of VD analogues .", "event": "<extra_id_0> <extra_id_1>"}
